PATENT CLAIM ANALYSIS

Application Number: 15731991
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "094200"]

Abstract:
The Cloning and Expression of Comosain's Minigene and the Methods and Compositions for treating and/or preventing various types of cancer which comprise administered an effective amount of Glyco-polypeptides and Bioflavonoids such as Comosain, Ananase, Bromelainases, Trypsin, Pepsin, Quercetin, Rutin, Naringenin, Genistein, Hesperetin, etc and/or a mixture thereof.

Claim (Index 9):
9 ). Isolation of Comosain mRNA.: The 4.8 kilobase Bst ty/se-Bam As/GL restriction fragment from Comosain was inserted into shuttle vector, pSV4ST. The resulting chimeric plasmid pSV gPLComo was used to transfect Cos-1 cells by the calcium phosphate micoprecipitate method. After culture for 72 hrs, RNA was prepared from the transected cells by the guanidinium thiocyanate procedure of Chirgwin et al. and poly (A)+ mRNA was isolated by binding to oligo-cellulose.(Aviv & Leder).

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.37209
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15272826', '14003629', '12861152', '11214831', '10617943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7113585368292376
- 35 USC 102 Novelty (BERT): 0.5205004779006374
- Combined Prediction Score: 0.6922727309363775
- Mean Citation Score: 172.64342000000005
- Max Citation Score: 186.47795
- Similarity Product: 86.86124334803074

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test